Characterization of the novel HLA-A*26:208 allele by sequencing-based typing.

Dard, Celine; Walencik, Alexandre; Oukasse, Imad; Bardy, Béatrice; Masson, Dominique

Dard, Celine; Walencik, Alexandre; Oukasse, Imad; Bardy, Béatrice; Masson, Dominique.

Afiliação

Dard C; Department of Biology and Therapies, Histocompatibility Laboratory, Etablissement Français du Sang Auvergne-Rhône-Alpes, Grenoble, France.
Walencik A; Histocompatibility laboratory, Etablissement Français du Sang Centre-Pays de la Loire, Nantes, France.
Oukasse I; Department of Biology and Therapies, Histocompatibility Laboratory, Etablissement Français du Sang Auvergne-Rhône-Alpes, Grenoble, France.
Bardy B; Department of Biology and Therapies, Histocompatibility Laboratory, Etablissement Français du Sang Auvergne-Rhône-Alpes, Grenoble, France.
Masson D; Department of Biology and Therapies, Histocompatibility Laboratory, Etablissement Français du Sang Auvergne-Rhône-Alpes, Grenoble, France.

HLA ; 97(6): 534-535, 2021 06.

Article em En | MEDLINE | ID: mdl-33709621

RESUMO

The novel HLA-A*26:208 allele was characterized using two next generation sequencing technologies.

Assuntos

Antígenos HLA; Sequenciamento de Nucleotídeos em Larga Escala; Alelos; Antígenos HLA-A/genética; Teste de Histocompatibilidade; Humanos; Análise de Sequência de DNA

Palavras-chave

HLA-A*26:208; NGS; human leucocyte antigen; novel HLA allele

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sequenciamento de Nucleotídeos em Larga Escala / Antígenos HLA Limite: Humans Idioma: En Revista: HLA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: França

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google